Both companies are renowned for their heady and fast-growing dividends. But which income investment is better?
With a soaring market, it's tempting to want to look for value. But here are some dangers to watch out for, including three stocks to avoid right now...
This big biotech might look more like a big pharma with sluggish growth but great dividends -- at least temporarily.
There's no special trick or complicated system to capturing these dividends -- you just have to know where to look. Details here.
In this company's most recent quarter, earnings per share jumped 29%.
Unless you're happy with ordinary yields of 2% to 3%, you might want to take a closer look at the closed-end fund market.
Buy one stock this September, and get shares of an upcoming spinoff in October.
Despite the longest bull market in history, some industries still look like bargains.
These under-the-radar energy stocks have delivered strong performance in 2018 and have plenty of fuel left in the tank.
The mainstream financial media liked to call this "Buffett's favorite indicator," but the truth may be very different. Here's my take...